Multiple Acyl Coenzyme A Dehydrogenase Deficiency: Clinical Trials

60 trials for Multiple Acyl Coenzyme A Dehydrogenase Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

49 completed, 6 unknown, 2 recruiting, 2 withdrawn. 25 Not applicable, 13 Phase 1, 8 Phase 2, 5 Phase 3, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable25Completed 23, Unknown 2
Phase 113Completed 11, Unknown 1, Withdrawn 1
Phase 28Completed 7, Withdrawn 1
Phase 35Completed 4, Terminated 1
Phase 44Completed 4

Follow Multiple Acyl Coenzyme A Dehydrogenase Deficiency: new trials by email Literature Review of Multiple Acyl Coenzyme A Dehydrogenase Deficiency trials Research Report on Multiple Acyl Coenzyme A Dehydrogenase Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Natural History of MADD
Multiple Acyl-CoA Dehydrogenase Deficiency
RecruitingIcahn School of Medicine at Mount Sinai502026-10-012026-09-16
Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis
Acyclovir 400 MG, Ganciclovir (GCV) - Herpetic Keratitis
Not applicableCompletedAl-Azhar University202024-10-012025-01-03
Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients
Cytomegalovirus Infections
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna1002023-06-192026-06-15
Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan
Obtaining Dry Blood Spots From Healthy Newborns (Aged 1-7 Days), Obtaining Dry Blood Spots From Healthy Children Aged 8 Days - 7 Years, Obtaining Dry Blood Spots From Healthy Children Aged 8-18 Years - Propionic/Methylmalonic Acidemias, Maple Syrup Urine Disease
UnknownWest Kazakhstan Medical University22502022-10-032023-06-18
Nexus of Risk: Sexual Assault, Alcohol Use, and Risky Sex Among College Women
Ecological Momentary Intervention - Sexual Assault, Substance Use
Not applicableCompletedUniversity of New Mexico1832018-10-012024-04-02
(Val)Ganciclovir TDM in Transplant Recipients
Ganciclovir, Valganciclovir - Cytomegalovirus Infections
UnknownUniversity Medical Center Groningen1002018-05-252019-10-10
Observational Study Comparing the Efficacy of Ganciclovir as a Function of Blood Exposure to the Drug During a Curative or Preemptive Treatment
Therapeutic Drug Monitoring - Solid Organ Transplantation
UnknownRennes University Hospital1382017-02-212023-04-12
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Gemcitabine, Valproic acid, Valganciclovir - Nasopharyngeal Carcinoma
Phase 1UnknownChang Gung Memorial Hospital182016-05-012016-05-16
Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
Sugar - Metabolism, Inborn Errors, Lipid Metabolism, Inborn Errors
Not applicableUnknownCopenhagen University Hospital, Rigshospitalet602016-01-012019-10-16
High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients
Ganciclovir - Infection Viral, Uveitis, Posterior
Not applicableCompletedAier School of Ophthalmology, Central South University332014-01-012018-07-26
CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")
Valganciclovir - Cytomegalovirus Infection
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2052012-10-292021-08-26
Topical Administration of 0.15% Ganciclovir Gel for CMV Anterior Uveitis / Endotheliitis
Ganciclovir - Cytomegalovirus Anterior Segment Infection, Anterior Uveitis
Not applicableCompletedSingapore National Eye Centre292012-07-012015-11-18
Cytomegalovirus Control in Critical Care
Valaciclovir/Aciclovir, Valganciclovir/Ganciclovir - Critical Illness
Phase 2CompletedUniversity Hospital Birmingham NHS Foundation Trust1242012-01-012015-01-12
Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
Valganciclovir, Ganciclovir - Allogeneic Stem Cell Transplantation
Phase 3TerminatedPierrel Research Europe GmbH2122010-09-012012-12-10
Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis
Ganciclovir, Artificial tear - Conjunctivitis, Viral, Adenoviridae Infections
Not applicableCompletedFederal University of São Paulo332009-08-012011-05-06
Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients
Single arm (ganciclovir and valganciclovir) - Cytomegalovirus Infection
Phase 4CompletedSalvador Gil-Vernet212004-03-012011-09-21
Valganciclovir in Congenital CMV Infants
Valganciclovir, Ganciclovir - Cytomegalovirus Infections
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)242002-07-012011-02-07
Neonatal CMV-Ganciclovir Follow-up Study
Cytomegalovirus Infections
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)82001-09-012011-08-12
Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients
Ganciclovir - DNA Virus Infection, Herpesviridae Infections
Phase 4CompletedLower Saxony Center for Nephrology1502000-08-012006-09-13
Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV
Valganciclovir - Cytomegalovirus Infections, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3502000-08-012021-11-01

Showing 20 of 60. Sign in to see all of them.

Narrower conditions

HIV Infections (40)  ·  Cytomegalovirus Infections (39)  ·  Acquired Immunodeficiency Syndrome (36)  ·  Cytomegalovirus Retinitis (30)  ·  Retinitis (25)  ·  AIDS-Related Opportunistic Infections (20)  ·  Carnitine palmitoyl transferase 2 deficiency (2)  ·  Colitis (2)  ·  Medium chain acyl CoA dehydrogenase deficiency (2)  ·  Metabolism, Inborn Errors (2)  ·  Neoplasm Metastasis (2)  ·  Systemic carnitine deficiency (2)  ·  Trifunctional Protein Deficiency With Myopathy And Neuropathy (2)  ·  VLCAD deficiency (2)

Broader conditions

Amino Acid Metabolism, Inborn Errors (60)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (60)  ·  Genetic Diseases, Inborn (60)  ·  Metabolic Diseases (60)  ·  Mitochondrial Diseases (60)  ·  Nutritional and Metabolic Diseases (60)  ·  Metabolism, Inborn Errors (58)  ·  Infections (51)  ·  Virus Diseases (50)  ·  DNA Virus Infections (49)  ·  Herpesviridae Infections (48)  ·  Blood-Borne Infections (40)  ·  Communicable Diseases (40)  ·  Genital Diseases (40)  ·  Immune System Diseases (40)

Interventions

Ganciclovir (44)  ·  Valganciclovir (9)  ·  Foscarnet (8)  ·  Zidovudine (4)  ·  Acyclovir (2)  ·  sargramostim (2)  ·  sevirumab (2)  ·  Aging (1)  ·  Cidofovir (1)  ·  Didanosine (1)  ·  Gemcitabine (1)  ·  Immunoglobulins (1)  ·  Interferon beta-1b (1)  ·  Lubricant Eye Drops (1)  ·  Probenecid (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (22)  ·  Hoffmann-La Roche (12)  ·  Roche Global Development (3)  ·  Aier School of Ophthalmology, Central South University (1)  ·  Al-Azhar University (1)  ·  American National Red Cross (1)  ·  Astra USA (1)  ·  Chang Gung Memorial Hospital (1)  ·  Chiron Corporation (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Federal University of São Paulo (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Ionis Pharmaceuticals, Inc. (1)  ·  Lower Saxony Center for Nephrology (1)

Countries

United States (45)  ·  Canada (4)  ·  Spain (3)  ·  France (2)  ·  Puerto Rico (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Finland (1)  ·  Germany (1)  ·  Italy (1)  ·  Kazakhstan (1)

Top investigators

Hardy WD (2)  ·  MA Jacobson (2)  ·  Borucki M (1)  ·  Brosgart C (1)  ·  C Crumpacker (1)  ·  CS Crumpacker (1)  ·  Cheng-Lung Hsu, Physican (1)  ·  Clifford D (1)  ·  Craig C (1)  ·  Dankner W (1)  ·  David A. Wohl, MD (1)  ·  Dieterich D (1)  ·  Feinberg J (1)  ·  Frenkel L (1)  ·  Gemmy Cheung (1)

Results publications

PMID 38700045, PMID 39807668, PMID 15498605, PMID 19632953, PMID 19738014, PMID 22331114, PMID 23665863, PMID 26416517, PMID 28437539, PMID 29377953, PMID 30526535, PMID 30990523, PMID 31492716, PMID 32286644, PMID 32726431, PMID 38283151

NIH funding

N01AI30025 (1)